|
Panacea
Biotec introduces anti-allergy drug
Panacea Biotec has launched Ralif (rupatadine 10 mg), novel anti-allergy
drug for the management of diseases with allergic inflammatory conditions,
such as seasonal and perennial allergic rhinitis.
Cadila
gets DCGI nod for phase I trial of NME
Cadila Healthcare Ltd has received permission from Drug Controller
General of India (DCGI) to conduct phase I clinical trials on its
New Molecular Entity (NME)-ZYH1.
Ranbaxy
acquires generic product portfolio from Efarmes
Ranbaxy Laboratories Limited has acquired a generic product portfolio
accounting for eighteen products belonging to the Spanish pharmaceutical
company Efarmes, SA for sale in the Spanish market.
Orchid’s
Chennai R&D centre receives GLP certification
The Chennai-based pharma major, Orchid Chemicals & Pharmaceuticals
Ltd (Orchid) has announced that its state-of-the-art Research &
Development (R&D) centre located in Chennai has received the
Good Laboratory Practices (GLP) certification.
Millipore
wins US Environment Protection Agency Award
Millipore, the life science lab equipment major, has bagged one
of the top US Awards for protecting the environment. The US Environment
Protection Agency (EPA), New England, finalised the winner as Millipore
for its work and commitment to the environment in 2004.
Emcure
signs MoU with Iceland-based Actavis Pharma
Emcure Pharmaceutical Limited and Actavis Pharma of Iceland signed
a Memorandum of Understanding (MoU) for close co-operation between
the two companies for supply of drugs to Russia and CIS countries.
German
Remedies launches Betaferon for multiple sclerosis
German Remedies, a part of the Zydus Group, has launched Interferon
beta-1b under the brand name Betaferon for the first time in India
for the treatment of multiple sclerosis (MS). Betaferon is a subcutaneous
injection and is the only Interferon efficacious even in the secondary
progressive stages of multiple sclerosis. The product is being marketed
in collaboration with Schering AG, Germany, according to a press
communique.
|
